American Century ETF Trust, American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research jointly filed a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership positions in Stepan Company common stock as of September 30, 2026.
Key Highlights
- American Century Investment Management aggregate stake: American Century Investment Management, Inc. reported beneficial ownership of 1,217,347 shares, representing 5.4% of Stepan Company common stock.
- American Century ETF Trust stake: American Century ETF Trust reported beneficial ownership of 1,157,812 shares, representing 5.1% of the class.
- Sole voting and dispositive power: All shares reported by each filer are held with sole voting power and sole dispositive power, with no shared voting or dispositive power reported.
- Parent holding company structure: American Century Companies, Inc. and Stowers Institute for Medical Research each reported the same 1,217,347 shares at 5.4%, reflecting their roles as holding company and control person, respectively.
- Event date: The date of the event requiring this filing is stated as September 30, 2026.
- Ordinary course certification: Each filer certified that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."
American Century Entities Cross 5% Threshold in Stepan Company
According to the filing, four related entities jointly submitted a Schedule 13G disclosing positions in Stepan Company (1101 Skokie Boulevard, Suite 500, Northbrook, Illinois, 60062) common stock. The reporting persons are organized in Delaware and share a principal business address of 4500 Main Street, 9th Floor, Kansas City, Missouri 64111. The filing was signed on November 16, 2026 by John Pak, Senior Vice President, on behalf of each entity.
The filing discloses that American Century Investment Management, Inc. (ACIM), classified as an investment adviser (type IA), beneficially owns 1,217,347 shares with sole voting and sole dispositive power over all such shares, equating to 5.4% of the class. American Century ETF Trust, classified as an investment company (type IV), separately reports 1,157,812 shares, also held with sole voting and sole dispositive power, representing 5.1% of the class. American Century Companies, Inc. (ACC), as a parent holding company (type HC), and Stowers Institute for Medical Research, also classified as a holding company (type HC), each report the same 1,217,347 shares and 5.4% figure, consistent with their structural relationship to ACIM.
The filing notes that ACIM is a wholly-owned subsidiary of ACC, which is controlled by the Stowers Institute for Medical Research, and that ACIM serves as investment adviser to various investment companies and separate institutional investor accounts. According to the filing, "various persons, including the investment companies and separate institutional investor accounts that American Century Investment Management, Inc. serves as investment adviser, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities." The filing further states that no single client advised by ACIM owns more than 5% of the class.
What Was Disclosed
Four affiliated entities filed a Schedule 13G reporting beneficial ownership in Stepan Company common stock as of September 30, 2026. American Century Investment Management, Inc. and related holding entities each disclosed 1,217,347 shares (5.4%), while American Century ETF Trust reported 1,157,812 shares (5.1%), all held with sole voting and dispositive power.




Please wait processing your request...